KRSA Stock Valuation & Analysis - InvestViable

Stock Screener

Valuator

Education

Pricing

Community

Home

Stock Screener

Valuator

Education

Pricing

Community

Institutional-grade investment tools for everyone. Built in Sweden. Trusted by investors worldwide.

Platform

Stock Screener

Valuator

Investment Score

Community

Education

Company

About

Pricing

Contact

Legal

Terms of Service

Privacy Policy

Cookie Policy

© 2026 INVESTVIABLE. All rights reserved.

KRSA Stock Valuation & Analysis - InvestViable

Korsana Biosciences, Inc.

S

NASDAQ

KRSA

Last Price

US $31.91

KEY FIGURES

MKT CAP

$149.4M

EPS

TTM

$-11.04

EPS Growth (1Y)

-9.92%

PEG

TTM

N/M

P/E

TTM

N/M

P/S

TTM

10.20x

YIELD

—

GROWTH (5Y CAGR)

Revenue

-

EBITDA

-

Cash flow

Base valuations

Base Cash Flow Valuation (DCF)

Fair Value

N/A

Market $31.91

—

Default assumptions

Base EBITDA Valuation

Fair Value

N/A

Market $31.91

—

Default assumptions

Base Earnings Fair Value

S

No messages

Performance & Financial Health

Profit margin

Current Ratio

Capital Returns

-87.96%

Return on equity

ROIC: -134.15%

Valuation History

-

Price to Earnings

EV/EBITDA: -22.1X

Cash flow

Profit margin

-

Fair Value

N/A

Market $31.91

—

Default assumptions

Base valuations use default assumptions. Customize in the Valuator.